News stories about Dynatronics (NASDAQ:DYNT) have trended somewhat positive recently, Accern reports. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Dynatronics earned a media sentiment score of 0.10 on Accern’s scale. Accern also assigned news headlines about the medical equipment provider an impact score of 45.9475295025741 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Separately, Zacks Investment Research raised shares of Dynatronics from a “sell” rating to a “hold” rating in a research note on Tuesday, November 21st.

Shares of Dynatronics (NASDAQ DYNT) opened at $2.90 on Tuesday. The company has a market cap of $14.27, a P/E ratio of -2.61 and a beta of -0.16. Dynatronics has a one year low of $2.10 and a one year high of $3.75. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.92 and a current ratio of 1.46.

Dynatronics (NASDAQ:DYNT) last issued its quarterly earnings data on Tuesday, November 14th. The medical equipment provider reported $0.00 EPS for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.08. The business had revenue of $12.80 million for the quarter. Dynatronics had a negative net margin of 3.42% and a negative return on equity of 45.78%. research analysts forecast that Dynatronics will post -0.09 earnings per share for the current fiscal year.

In related news, major shareholder Ventures 1 Lp Provco purchased 300,000 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The shares were purchased at an average price of $2.50 per share, with a total value of $750,000.00. Following the purchase, the insider now owns 586,944 shares of the company’s stock, valued at $1,467,360. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Brian Larkin purchased 40,000 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The stock was bought at an average cost of $2.50 per share, for a total transaction of $100,000.00. Following the purchase, the director now directly owns 80,276 shares in the company, valued at approximately $200,690. The disclosure for this purchase can be found here. 51.80% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY NOTICE: This piece was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://theolympiareport.com/2017/12/26/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-dynatronics-dynt-share-price.html.

About Dynatronics

Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.

Insider Buying and Selling by Quarter for Dynatronics (NASDAQ:DYNT)

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.